312 related articles for article (PubMed ID: 30934860)
21. Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3.
Thilakasiri P; O'Keefe RN; To SQ; Chisanga D; Eissmann MF; Carli AL; Duscio B; Baloyan D; Dmello RS; Williams D; Mariadason J; Poh AR; Pal B; Kile BT; Vissers JH; Harvey KF; Buchert M; Shi W; Ernst M; Chand AL
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 37957015
[TBL] [Abstract][Full Text] [Related]
22. The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
Kaneda A; Seike T; Danjo T; Nakajima T; Otsubo N; Yamaguchi D; Tsuji Y; Hamaguchi K; Yasunaga M; Nishiya Y; Suzuki M; Saito JI; Yatsunami R; Nakamura S; Sekido Y; Mori K
Am J Cancer Res; 2020; 10(12):4399-4415. PubMed ID: 33415007
[TBL] [Abstract][Full Text] [Related]
23. Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction.
Dupont S
Exp Cell Res; 2016 Apr; 343(1):42-53. PubMed ID: 26524510
[TBL] [Abstract][Full Text] [Related]
24. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy.
Guo Q; Quan M; Dong J; Bai J; Wang J; Han R; Wang W; Cai Y; Lv YQ; Chen Q; Xu H; Lyu HD; Deng L; Zhou D; Xiao X; De Langhe S; Billadeau DD; Lou Z; Zhang JS
Theranostics; 2020; 10(10):4422-4436. PubMed ID: 32292505
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.
Li YW; Guo J; Shen H; Li J; Yang N; Frangou C; Wilson KE; Zhang Y; Mussell AL; Sudol M; Farooq A; Qu J; Zhang J
Cell Cycle; 2016 Sep; 15(18):2497-505. PubMed ID: 27428284
[TBL] [Abstract][Full Text] [Related]
26. YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma.
Kuo YZ; Kang YR; Chang WL; Sim LC; Hsieh TC; Chang CH; Wang YC; Tsai CJ; Huang LC; Tsai ST; Wu LW
Cell Oncol (Dordr); 2022 Oct; 45(5):893-909. PubMed ID: 35930163
[TBL] [Abstract][Full Text] [Related]
27. RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription.
Wang J; Huang F; Shi Y; Zhang Q; Xu S; Yao Y; Jiang R
Gastric Cancer; 2021 Jan; 24(1):85-102. PubMed ID: 32623586
[TBL] [Abstract][Full Text] [Related]
28. Chasing Hippos: Implications of YAP1 and TAZ Expression in Pregnancy-associated Breast Cancer Tumorigenesis.
Kyriazoglou A; Korakiti AM; Papatheodoridi AM; Apostolidou K; Nonni A; Zografos E; Bletsa G; Tsakogiannis D; Dimopoulos MA; Zagouri F
In Vivo; 2022; 36(6):2869-2874. PubMed ID: 36309401
[TBL] [Abstract][Full Text] [Related]
29. Distinct prognostic values of YAP1 in gastric cancer.
Yu L; Gao C; Feng B; Wang L; Tian X; Wang H; Ma D
Tumour Biol; 2017 Apr; 39(4):1010428317695926. PubMed ID: 28381174
[TBL] [Abstract][Full Text] [Related]
30. Emerging role of Hippo signalling pathway in bladder cancer.
Xia J; Zeng M; Zhu H; Chen X; Weng Z; Li S
J Cell Mol Med; 2018 Jan; 22(1):4-15. PubMed ID: 28782275
[TBL] [Abstract][Full Text] [Related]
31. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Zhou Q; Bauden M; Andersson R; Hu D; Marko-Varga G; Xu J; Sasor A; Dai H; Pawłowski K; Said Hilmersson K; Chen X; Ansari D
J Transl Med; 2020 Feb; 18(1):77. PubMed ID: 32054505
[TBL] [Abstract][Full Text] [Related]
32. Fluid shear stress activates YAP1 to promote cancer cell motility.
Lee HJ; Diaz MF; Price KM; Ozuna JA; Zhang S; Sevick-Muraca EM; Hagan JP; Wenzel PL
Nat Commun; 2017 Jan; 8():14122. PubMed ID: 28098159
[TBL] [Abstract][Full Text] [Related]
33. Vinculin promotes nuclear localization of TAZ to inhibit ECM stiffness-dependent differentiation into adipocytes.
Kuroda M; Wada H; Kimura Y; Ueda K; Kioka N
J Cell Sci; 2017 Mar; 130(5):989-1002. PubMed ID: 28115535
[TBL] [Abstract][Full Text] [Related]
34. Activation of Yap1/Taz signaling in ischemic heart disease and dilated cardiomyopathy.
Hou N; Wen Y; Yuan X; Xu H; Wang X; Li F; Ye B
Exp Mol Pathol; 2017 Dec; 103(3):267-275. PubMed ID: 29154888
[TBL] [Abstract][Full Text] [Related]
35. Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis.
Szulzewsky F; Arora S; Hoellerbauer P; King C; Nathan E; Chan M; Cimino PJ; Ozawa T; Kawauchi D; Pajtler KW; Gilbertson RJ; Paddison PJ; Vasioukhin V; Gujral TS; Holland EC
Genes Dev; 2020 Aug; 34(15-16):1051-1064. PubMed ID: 32675324
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.
Zhang J; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(4):977-87. PubMed ID: 23298488
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1.
Ben C; Wu X; Takahashi-Kanemitsu A; Knight CT; Hayashi T; Hatakeyama M
J Biol Chem; 2020 Oct; 295(41):13965-13980. PubMed ID: 32763976
[TBL] [Abstract][Full Text] [Related]
38. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
Ishihara E; Nishina H
Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside.
Liu X; Wang Y; Chen B; Chan WN; Mui CW; Cheung AHK; Zhang J; Wong KY; Yu J; Kang W; To KF
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289774
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
